![]()
Los Angeles Times
![]()
'Paradigm change' in the development of cancer drugsWashington PostThe National Cancer Institute's announcement Monday that it will soon begin a nationwide trial to test treatments based on the genetic mutations in patients' tumors, rather than on where the tumors occur in the body, highlights a profound shift taking ...Large US cancer trial to match genetic glitches to targeted drugsReutersMassive cancer test to study genetic targetingSan Jose Mercury NewsCancer trials aim to shore up 'precision medicine's' base of evidenceLos Angeles Timesall 93 news articles »